NeXT Personal identifies circulating tumor DNA in 81% of early-stage lung adenocarcinoma cases, offering potential for better disease stratification and outcome prediction. Study: Ultrasensitive ctDNA ...
A technology has been developed that can screen for lung cancer at an early stage using exhaled breath. This technology demonstrated 95% accuracy in clinical settings. It is expected to contribute to ...
Turkish scientists have developed an artificial intelligence-supported application designed to detect lung cancer at an early stage by analyzing a person's voice. Led by Dr. Haydar Ankishan from the ...
Please provide your email address to receive an email when new articles are posted on . Patients with limited-stage small cell lung cancer with ctDNA positivity after chemotherapy had significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results